Sabby Management, LLC Xenon Pharmaceuticals Inc. Transaction History

Sabby Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$4.8 - $9.2 $321,600 - $616,400	-67,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.7 - $4.9 $708,480 - $1.29 Million	-262,400 Reduced 79.66%	67,000 $328,000
Q4 2017 Feb 14, 2018	BUY	$2.2 - $3.25 $47,960 - $70,850	21,800 Added 7.09%	329,400 $931,000
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.25 $753,620 - $999,700	307,600	307,600 $907,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.